These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7728619)

  • 21. Treatment of aspirin-intolerant asthma with antileukotrienes.
    Dahlén B
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S137-41. PubMed ID: 10673243
    [No Abstract]   [Full Text] [Related]  

  • 22. Cellular allergen stimulation test with acetylsalicylic acid-lysine is not a useful test to discriminate between asthmatic patients with and without acetylsalicylic acid sensitivity.
    Bavbek S; Dursun AB; Birben E; Kalayci O; Misirligil Z
    Int Arch Allergy Immunol; 2009; 149(1):58-64. PubMed ID: 19033733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects.
    Christie PE; Tagari P; Ford-Hutchinson AW; Black C; Markendorf A; Schmitz-Schumann M; Lee TH
    Am Rev Respir Dis; 1992 Dec; 146(6):1531-4. PubMed ID: 1333741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchial hyperresponsiveness, hypersensitivity to analgesics and urinary leukotriene E4 excretion in patients with aspirin-intolerant asthma.
    Yoshida S; Nakagawa H; Yamawaki Y; Sakamoto H; Akahori K; Nakabayashi M; Sakamoto M; Hasegawa H; Shoji T; Tajimab T; Amayasu H
    Int Arch Allergy Immunol; 1998 Oct; 117(2):146-51. PubMed ID: 9784659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin provocation increases 8-iso-PGE2 in exhaled breath condensate of aspirin-hypersensitive asthmatics.
    Mastalerz L; Januszek R; Kaszuba M; Wójcik K; Celejewska-Wójcik N; Gielicz A; Plutecka H; Oleś K; Stręk P; Sanak M
    Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):163-9. PubMed ID: 26209241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Nasal provocation test with lysine-aspirin in diagnosis of nonallergic rhinitis with eosinophilia].
    Modrzyński M; Mazurek H; Zawisza E
    Otolaryngol Pol; 2006; 60(1):25-31. PubMed ID: 16821537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of inhaled lysine acetylsalicylate (L-ASA) on bradykinin-induced bronchoconstriction in asthmatics: evidence of contribution of prostaglandins.
    Polosa R; Milazzo VL; Magrì S; Pagano C; Paolino G; Santonocito G; Prosperini G; Crimi N
    Eur Respir J; 1997 Apr; 10(4):866-71. PubMed ID: 9150326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma.
    Sestini P; Armetti L; Gambaro G; Pieroni MG; Refini RM; Sala A; Vaghi A; Folco GC; Bianco S; Robuschi M
    Am J Respir Crit Care Med; 1996 Feb; 153(2):572-5. PubMed ID: 8564100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iontophoretic administration of pirprofen or lysine soluble aspirin in the treatment of rheumatic diseases.
    Garagiola U; Dacatra U; Braconaro F; Porretti E; Pisetti A; Azzolini V
    Clin Ther; 1988; 10(5):553-8. PubMed ID: 2856598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled lysine acetylsalicylate (L-ASA) attenuates histamine-induced bronchoconstriction in asthma.
    Crimi N; Polosa R; Magrì S; Prosperini G; Paolino G; Mastruzzo C; Mistretta A
    Allergy; 1996 Mar; 51(3):157-63. PubMed ID: 8781669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bronchodilatory and anti-inflammatory properties of inhaled selective phosphodiesterase inhibitors in a guinea pig model of allergic asthma.
    Santing RE; de Boer J; Rohof A; van der Zee NM; Zaagsma J
    Eur J Pharmacol; 2001 Oct; 429(1-3):335-44. PubMed ID: 11698054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.
    Dahlén B; Nizankowska E; Szczeklik A; Zetterström O; Bochenek G; Kumlin M; Mastalerz L; Pinis G; Swanson LJ; Boodhoo TI; Wright S; Dubé LM; Dahlén SE
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1187-94. PubMed ID: 9563738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin and asthma.
    Babu KS; Salvi SS
    Chest; 2000 Nov; 118(5):1470-6. PubMed ID: 11083703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiation of the antireactive, antiasthmatic effect of inhaled furosemide by inhaled lysine acetylsalicylate.
    Bianco S; Vaghi A; Pieroni MG; Robuschi M; Refini RM; Berni F; Sestini P
    Allergy; 1993 Nov; 48(8):570-5. PubMed ID: 8116856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of aspirin-induced asthma combining the bronchial and the oral challenge tests: a pilot study.
    Barranco P; Bobolea I; Larco JI; Prior N; López-Serrano MC; Quirce S
    J Investig Allergol Clin Immunol; 2009; 19(6):446-52. PubMed ID: 20128418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics.
    Dahlén B; Kumlin M; Margolskee DJ; Larsson C; Blomqvist H; Williams VC; Zetterström O; Dahlén SE
    Eur Respir J; 1993 Jul; 6(7):1018-26. PubMed ID: 8396534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mild intermittent aspirin-induced asthma in a patient who became asymptomatic after removal of pet hamsters from home].
    Kawai K; Shirai T; Suzuki K; Chida K; Nakamura H
    Nihon Kokyuki Gakkai Zasshi; 2000 Apr; 38(4):298-301. PubMed ID: 10879034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic responses after bronchial aspirin challenge in sensitive patients with asthma.
    Makowska JS; Grzegorczyk J; Bienkiewicz B; Wozniak M; Kowalski ML
    J Allergy Clin Immunol; 2008 Feb; 121(2):348-54. PubMed ID: 18086495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nasal provocation tests in the diagnosis of urticaria induced by acetylsalicylic acid.
    Tomaz EM; Ferreira MF; Spínola MA; Oliveira ML; Clode MH; Palma-Carlos AG
    Allergy Asthma Proc; 1997; 18(5):319-22. PubMed ID: 9337427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Severe bullous forms of drug eruptions].
    Sfar Z; Belkahia C; Kamoun M
    Tunis Med; 1989 Dec; 67(12):805-8. PubMed ID: 2533762
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.